Frontiers in Immunology (Apr 2022)

Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray

  • Sina Hosseinian,
  • Kathleen Powers,
  • Milind Vasudev,
  • Anton M. Palma,
  • Rafael de Assis,
  • Aarti Jain,
  • Peter Horvath,
  • Paramveer S. Birring,
  • Rana Andary,
  • Connie Au,
  • Brandon Chin,
  • Ghali Khalil,
  • Jenny Ventura,
  • Madeleine K. Luu,
  • Cesar Figueroa,
  • Joshua M. Obiero,
  • Emily Silzel,
  • Rie Nakajima,
  • William Thomas Gombrich,
  • Algis Jasinskas,
  • Frank Zaldivar,
  • Frank Zaldivar,
  • Sebastian Schubl,
  • Sebastian Schubl,
  • Philip L. Felgner,
  • Saahir Khan,
  • The Specimen Collection Group

DOI
https://doi.org/10.3389/fimmu.2022.817345
Journal volume & issue
Vol. 13

Abstract

Read online

Recent studies provide conflicting evidence on the persistence of SARS-CoV-2 immunity induced by mRNA vaccines. Here, we aim to quantify the persistence of humoral immunity following vaccination using a coronavirus antigen microarray that includes 10 SARS-CoV-2 antigens. In a prospective longitudinal cohort of 240 healthcare workers, composite SARS-CoV-2 IgG antibody levels did not wane significantly over a 6-month study period. In the subset of the study population previously exposed to SARS-CoV-2 based on seropositivity for nucleocapsid antibodies, higher composite anti-spike IgG levels were measured before the vaccine but no significant difference from unexposed individuals was observed at 6 months. Age, vaccine type, or worker role did not significantly impact composite IgG levels, although non-significant trends towards lower antibody levels in older participants and higher antibody levels with Moderna vaccine were observed at 6 months. A small subset of our cohort were classified as having waning antibody titers at 6 months, and these individuals were less likely to work in patient care roles and more likely to have prior exposure to SARS-CoV-2.

Keywords